Return to homepagePandemic Pact

Screening for antiviral compounds active against COVID-19

  • Funded by HRB Ireland, Irish Research Council
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $224,479.66

  • Funder

    HRB Ireland, Irish Research Council

  • Principal Investigator

    Dr. Virginie Gautier

  • Research Location

    Ireland

  • Lead Research Institution

    University College Dublin

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

UCD CEPHR is focused on accelerating the development of COVID-19 treatments, we have mobilised our collaborators, resources and expertise to deliver a full COVID-19 antiviral pipeline. Our goal is to identify effective antiviral drugs to be included as part of new therapeutic interventions to reduce COVID-19 disease burden'